Sub-cutaneous Fat Mass measured on multislice computed tomography of pretreatment PET/CT is a prognostic factor of stage IV non-small cell lung cancer treated by nivolumab

Sub-cutaneous Fat Mass measured on multislice computed tomography of pretreatment PET/CT is a prognostic factor of stage IV non-small cell lung cancer treated by nivolumab

Introduction: Our aim was to explore the prognostic value of anthropometric parameters in patients treated with nivolumab for stage IV non-small cell lung cancer (NSCLC). Methods: We retrospectively included 55 patients with NSCLC treated by nivolumab with a pretreatment 18FDG positron emission tomo...

Full description

Bibliographic Details
Main Authors: Geoffrey Popinat, Stéphanie Cousse, Lucas Goldfarb, Stéphanie Becker, Isabelle Gardin, Mathieu Salaün, Sébastien Thureau, Pierre Vera, Florian Guisier, Pierre Decazes
Format: Article
Language:English
Published: Taylor & Francis Group 2019-05-01
Series:OncoImmunology
Subjects:
body composition
immunotherapy
positron emission tomography
computed tomography
prognostic factor
predictive factor
nuclear medicine
non-small cell lung carcinoma
personalized medicine
nivolumab
Online Access:http://dx.doi.org/10.1080/2162402X.2019.1580128

Similar Items

Similar Items